Showing results (201-210 of 1,959) with videos related to

Sort By:
Pageof 196
Circulation Research|January 10, 2023
Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet AgentsJunchao Xu, Na Yan, Chunling Wang, et al.
Biomaterials|May 28, 2018
Delivery of small interfering RNA against Nogo-B receptor via tumor-acidity responsive nanoparticles for tumor vessel normalization and metastasis suppressionBin Wang, Yanping Ding, Xiaozheng Zhao, et al.
Advanced Healthcare Materials|December 15, 2018
Total Aqueous Synthesis of Au@Cu2-x S Core-Shell Nanoparticles for In Vitro and In Vivo SERS/PA Imaging-Guided Photothermal Cancer TherapyQian Lv, Huan Min, Dong-Ban Duan, et al.
Nature Communications|August 25, 2018
Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystemXuexiang Han, Yiye Li, Ying Xu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 10, 2015
Hepcidin levels in hyperprolactinemic women monitored by nanopore thin film based assay: correlation with pregnancy-associated hormone prolactinJing Wang, Gang Liu, Zi Xu, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 7, 2022
Probiotic-Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut MicrobiomeJiaqi Xu, Junchao Xu, Tongfei Shi, et al.
Antioxidants & Redox Signaling|February 4, 2010
Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's diseaseZhen-Hua Shi, Guangjun Nie, Xiang-Lin Duan, et al.
ACS Nano|March 23, 2019
An Extendable Star-Like Nanoplatform for Functional and Anatomical Imaging-Guided Photothermal OncotherapyXuexiang Han, Ying Xu, Yiye Li, et al.
Angewandte Chemie (International Ed. in English)|November 24, 2025
Ionizable Nano-PROTAC Overcomes Endosomal Entrapment for Enhanced LRG1 Degradation and Tumor SuppressionHuan Min, Ming Chao Sun, Kaijing Hu, et al.
Cell Chemical Biology|February 3, 2024
Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptorLing-Yan Su, Yang Tian, Qiang Zheng, et al.
Pageof 196